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Abstract 20	
 Maintenance of adaptive genetic variation has long been a goal of management of natural 21	
populations, but only recently have genomic tools allowed identification of specific loci 22	
associated with fitness-related traits in species of conservation concern. This raises the 23	
possibility of managing for genetic variation directly relevant to specific threats, such as those 24	
due to climate change or emerging infectious disease. Tasmanian devils (Sarcophilus harrisii) 25	
face the threat of a transmissible cancer, devil facial tumor disease (DFTD), that has decimated 26	
wild populations and led to intensive management efforts. Recent discoveries from genomic and 27	
modeling studies reveal how natural devil populations are responding to DFTD, and can inform 28	
management of both captive and wild devil populations. Notably, recent studies have 29	
documented genetic variation for disease-related traits and rapid evolution in response to DFTD, 30	
as well as potential mechanisms for disease resistance such as immune response and tumor 31	
regression in wild devils. Recent models predict dynamic persistence of devils with or without 32	
DFTD under a variety of modeling scenarios, although at much lower population densities than 33	
before DFTD emerged, contrary to previous predictions of extinction. As a result, current 34	
management that focuses on captive breeding and release for maintaining genome-wide genetic 35	
diversity or demographic supplementation of populations could have negative consequences. 36	
Translocations of captive devils into wild populations evolving with DFTD can cause 37	
outbreeding depression and/or increases in the force of infection and thereby the severity of the 38	
epidemic, and we argue that these risks outweigh any benefits of demographic supplementation 39	
in wild populations. We also argue that genetic variation at loci associated with DFTD should be 40	
monitored in both captive and wild populations, and that as our understanding of DFTD-related 41	
genetic variation improves, considering genetic management approaches to target this variation 42	
is warranted in developing conservation strategies for Tasmanian devils. 43	
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Introduction 49	
The maintenance or enhancement of genetic diversity has long been a focus of 50	
conservation efforts to manage declining, threatened or endangered species (Soulé and Wilcox 51	
1980). Early efforts focused on ensuring a minimum effective population size to prevent loss of 52	
alleles via genetic drift and avoidance of demographic processes that could lead to inbreeding 53	
(Gilpin and Soulé 1986; Lande 1995). The development of genetic tools such as microsatellites 54	
allowed direct monitoring of genetic diversity and facilitated more active genetic management, 55	
such as genetic rescue, which involves introducing genetic variation into a threatened population 56	
to increase population fitness (Frankham 2015; Whiteley et al. 2015). For example, 57	
translocations likely prevented extinction and even facilitated recovery in the Florida panther, 58	
which suffered from inbreeding depression prior to introduction of animals from Texas (Johnson 59	
et al. 2010).  60	
Whereas management of overall genetic diversity is a general strategy for maximizing 61	
evolutionary potential in the face of uncertain environmental change (Gilpin and Soulé 1986), we 62	
are now in the midst of an era of urgent and specific threats coming from anthropogenic global 63	
change. With the advent of genomic techniques, researchers can identify loci responsible for 64	
reduced fitness (Kardos et al. 2016), associated with variation in phenotypic traits (Santure and 65	
Garant 2018), or associated with adaptive differentiation among populations and adaptation to 66	
specific environmental factors (Rellstab et al. 2015; Hoban et al. 2016; Storfer et al. 2018a). 67	
Numerous studies have identified such loci in natural populations (reviewed by Luikart et al. 68	
2018), and Bay et al. (2018) provide an approach for using genomic information on adaptive loci 69	
in predictive modeling of species responses to specific and immediate threats, such as climate 70	
change or emerging infectious diseases. However, when and how to tailor active conservation 71	
efforts based on information about particular loci versus overall genetic variation remains a 72	
challenging question.  73	
 Tasmanian devils (Sarcophilus harrisii) are a prime example of a species facing a 74	
specific threat. Once native to mainland Australia and the island of Tasmania, these marsupial 75	
carnivores were restricted to the island state of Tasmania by the time of European colonization 76	
(Brüniche-Olsen et al. 2018). Devils appear to have experienced genetic bottlenecks prior to the 77	
contraction of their distribution to Tasmania, which affected genetic diversity at immune-related 78	
(Morris et al. 2013) and neutral loci, likely resulting from climatic changes associated with 79	
extreme El Niño events 3,000-5,000 years ago and the glacial maximum more than 20,000 years 80	
ago (Brüniche-Olsen et al. 2014). Thus far, all genetic studies of devils have shown low genetic 81	
diversity in microsatellites (Jones et al. 2004; Lachish et al. 2011; Brüniche-Olsen et al. 2014), 82	
mitochondrial genomes (Miller et al. 2011; Brüniche-Olsen et al. 2018), MHC class I (Siddle et 83	
al. 2010) and class II (Cheng et al. 2012) loci, and RADseq-derived SNPs (Hendricks et al. 84	
2017). Since the mid-1990s, Tasmanian devil populations have declined progressively island-85	
wide as a result of the appearance and spread of devil facial tumor disease (DFTD), a 86	
transmissible cancer (Pearse and Swift 2006; Murchison 2009). Transmitted by biting during 87	
common social interactions among devils, DFTD is almost always fatal (McCallum et al. 2009; 88	
Hamede et al. 2013). In just over 20 years, this clonal cell line has spread approximately 95% of 89	
the way across the devil's geographic range, causing localized declines often exceeding 90% and 90	
a species-wide decline of approximately 80% (McCallum et al. 2009; Hamede et al. 2015; 91	
Lazenby et al. 2018; Storfer et al. 2018b). The severity of this outbreak led to predictions of 92	
complete extinction of devils, based on compartmental epidemiological models with frequency-93	
dependent transmission of DFTD (McCallum et al. 2009). However, no local extinctions have 94	
been documented (Lazenby et al. 2018; Storfer et al. 2018b). 95	
 96	
Recent findings in Tasmanian devils and DFTD 97	
 A number of recent studies have provided a better understanding of the impacts of DFTD 98	
on devil populations and insights into potential future outcomes (Storfer et al. 2018b; Russell et 99	
al. 2018). A large amount of research has focused on the physiological and immunological 100	
responses of individual devils to DFTD infection (e.g., Siddle et al. 2013; Brown et al. 2016) and 101	
genetic changes in the tumor cell line (e.g., Pearse et al. 2012; Ujvari et al. 2013); here we focus 102	
on genetic variation and the potential population responses to disease.  103	
Recent genomic studies have found evidence of both genetic variation for DFTD-related 104	
phenotypes and rapid evolution of devils at loci with functions potentially related to DFTD 105	
resistance and transmission (see Supplemental Table S1 for a list of the candidate genes 106	
identified by these studies). Epstein et al. (2016) scanned 90,000 SNP loci for multiple signatures 107	
of selective sweeps (large changes in allele frequencies pre- and post-disease, increases in 108	
linkage disequilibrium, and time-series analyses) in three independent devil populations across a 109	
wide geographic area. Strong support was found for rapid evolution (in 4-6 generations) in two 110	
small genomic regions containing seven candidate genes, five of which were associated with 111	
immune and cancer-related functions (Epstein et al. 2016). In a second study, Hubert et al. 112	
(2018) re-analyzed the same dataset using a maximum likelihood approach and extensive 113	
functional annotations, and they found evidence for responses to selection in 97 genomic regions 114	
containing 148 protein coding genes. Nearly all of these loci with human orthologs were linked 115	
with cancer, and many with behavior (Hubert et al. 2018). More directly, a genome-wide 116	
association study (GWAS) of 624 devils at nearly 16,000 SNP loci explained much of the 117	
phenotypic variance for survival of females with DFTD (>80%) and female case-control (>61%) 118	
(Margres et al. 2018a). Notably, for female survival a large proportion of the variance (>61%) 119	
was explained by relatively few (~5) large-effect SNP loci. 120	
 Remarkably, a small but growing number (fewer than 20) of devils have recently shown 121	
tumor regression or even complete tumor disappearance after DFTD infection (Pye et al. 2016a; 122	
Wright et al. 2017). A comparative genomic study of devils with tumor regression versus those 123	
that succumbed to DFTD showed evidence that three genes involved in the regression process 124	
likely stimulate angiogenesis in cancer metastases, perhaps enabling increased tumor 125	
vascularization to enable lymphocyte penetration (Wright et al. 2017). A second comparative 126	
genomic study suggested that regulatory changes in gene expression were involved (Margres et 127	
al. 2018b). Additionally, wild devils have recently shown evidence of an apparently effective 128	
immune response (Pye et al. 2016a) with circulating lymphocytes that infiltrate the tumor, as 129	
well as circulating antibodies against DFTD. 130	
Despite models predicting devil extinction (McCallum et al. 2009), the longest diseased 131	
populations persist (Lazenby et al. 2018), and more recent modeling efforts are beginning to 132	
explain this observation. Based on long-term field study of the West Pencil Pine population 133	
located near Cradle Mountain, Wells et al. (2017) found that force of infection, the rate at which 134	
susceptible individuals become infected, began to decline roughly six years after disease 135	
appearance, and that devils that get infected with DFTD are otherwise more fit than those that do 136	
not. Additionally, survival after infection is 12-24 months, longer than previous field estimates of 137	
3-9 months based on recapture data (Wells et al. 2017). Two epidemiological models at different 138	
spatial scales (Siska et al. 2018; Wells et al. 2019) also predict persistence of devils over a wide 139	
range of scenarios, without explicitly incorporating genetic changes. Wells et al. (2019) predict 140	
devil persistence with or without DFTD in single populations, by including tumor growth and 141	
individual variation in tumor load, in approximately 80% of simulations. At the metapopulation 142	
level, Siska et al. (2018) predict dynamic, long-term coexistence of devils and DFTD, using 143	
models that incorporate spatial movement, local extinction, and recolonization. 144	
 145	
Current conservation strategies for Tasmanian devils 146	
 There are several strategies that have been proposed to manage the impact of DFTD on 147	
wild Tasmanian devil populations (Jones et al. 2007; McCallum 2008), although some have 148	
proven ineffective or unfeasible. Removing diseased animals, or culling, was unsuccessful when 149	
attempted (Lachish et al. 2010), and models have shown that no feasible culling strategy exists 150	
because of the need for unachievably high capture rates (Beeton and McCallum 2011). Isolation 151	
of a disease-free population, for instance on islands or by fencing, has also been proposed 152	
(McCallum and Jones 2010; Huxtable et al. 2015). However, fencing and related strategies are 153	
impractical because devils form a relatively continuous metapopulation across the species range 154	
(Hendricks et al. 2017) with few natural barriers (Storfer et al. 2017), and DFTD has spread 155	
across nearly the entire topographically rugged range with few remaining disease-free 156	
populations. As a result, two primary conservation strategies are currently being pursued: captive 157	
breeding and release, and vaccine development.  158	
 First, a captive insurance metapopulation distributed across a number of locations was 159	
established in 2006 with the goal of maintaining a disease-free population that is “genetically 160	
representative of the species” (CBSG/DPIPWE/ARAZPA 2009). The insurance population has 161	
been managed using a pedigree approach geared to maximize genetic diversity across the 162	
genome (Hogg et al. 2015; Grueber et al. 2018). Genetic marker panels have been developed to 163	
monitor genetic diversity (Wright et al. 2015), and genetic data may provide more accurate 164	
information than pedigree estimates to minimize inbreeding and loss of variation (Hogg et al. 165	
2018). A disease-free population was established on Maria Island, derived from the captive 166	
insurance population (Thalmann et al. 2016). McLennan et al. (2018) estimated a pedigree for 167	
this population based on a panel of microsatellite loci and predicted substantial loss of genetic 168	
variation, suggesting that the small size of this population limits its utility for long-term 169	
conservation efforts in the absence of continued supplementation. A disease-free population was 170	
also established on the Forestier Peninsula, which is connected to mainland Tasmania by a road 171	
bridge across a human-made canal. Devils were first eradicated from the 64,000 hectare 172	
peninsula and then disease-free individuals introduced from the captive population (Huxtable et 173	
al. 2015). Despite the use of genetic markers to quantify variation and estimate pedigree 174	
relationships, genetic management of the captive population has not focused specifically on loci 175	
associated with DFTD.  176	
 An original goal of the insurance population was to be a source for reintroduction 177	
following local extinction of devil populations (CBSG/DPIPWE/ARAZPA 2009), although no 178	
local extinctions have since been documented. Nonetheless the Tasmanian government has 179	
released more than 80 animals from the insurance population into the wild, with the stated 180	
objectives of boosting devil population size and increasing genetic diversity (DPIPWE 2018). 181	
Behavioral changes and possibly domestication selection have reduced the fitness of individuals 182	
released from the insurance population, including increased vulnerability to vehicle mortality 183	
(Grueber et al. 2017). Currently, genetic variation at specific loci showing signatures of selection 184	
in response to DFTD, or associated with DFTD-related phenotypes such as tumor regression, is 185	
not considered in assessing individuals for release into wild populations.  186	
 Second, researchers are investigating the development of a vaccine that could be 187	
delivered to wild devils. The prospect of success is supported by progress in understanding 188	
immune responses in devils (Brown et al. 2011, 2016; Kreiss et al. 2015) and the observations of 189	
tumor regression and immune response in wild populations described above (Pye et al. 2016a). 190	
Experimentally treating devils with radiation-killed DFTD cells can produce a detectable 191	
immune response, which in some cases led to tumor regression in captive animals (Tovar et al. 192	
2017). Pye et al. (2018) found that devils treated with DFTD cells manipulated to produce MHC 193	
class I antigens induce an antibody response in devils released into the wild. Yet despite this 194	
progress, it is not yet known whether immunization may be protective against DFTD infection in 195	
the field. 196	
 197	
Genetic management and future directions 198	
Current conservation efforts in Tasmanian devils are geared toward maintenance of 199	
overall genetic diversity in captivity, to release of individuals into existing wild populations to 200	
supplement overall genetic variation and demographic population sizes, and to mitigate the 201	
extent of ecosystem change due to trophic cascades (CBSG/DPIPWE/ARAZPA 2009; Huxtable 202	
et al. 2015). However, devils have the potential to be a model system for designing conservation 203	
strategies focused on adaptive genetic diversity. Devils have been the subject of long-term mark-204	
recapture studies throughout the species range, with phenotypic data and tissue samples collected 205	
from over 10,000 individuals in addition to over 2,000 tumor biopsies. Traditional genetic tools 206	
such as Sanger sequencing (Cheng et al. 2012) and microsatellite loci (Jones et al. 2003) have 207	
been widely applied, and microsatellites are used in genetic monitoring and pedigree estimation 208	
in the captive population (Hogg et al. 2015, 2016). Genomic tools include devil reference 209	
genome and transcriptome sequences (Murchison et al. 2012), tumor genome sequences 210	
(Stammnitz et al. 2018), comparative genomics (Wright et al. 2017; Margres et al. 2018b), and a 211	
number of genetic marker panels (Siddle et al. 2010; Morris et al. 2015; Wright et al. 2015; 212	
Epstein et al. 2016; Margres et al. 2018a). Given these resources and substantial novel results, it 213	
is timely to re-evaluate a few basic questions about strategies for devil conservation: What is 214	
likely to happen to devil populations in the absence of management actions? What are the 215	
benefits and risks of the ongoing management actions on devil populations, and how do they 216	
change predicted future outcomes? What is the best management strategy to maintain adaptive 217	
potential in devils, in the face of DFTD as well as other environmental changes, into the future?  218	
 Recent results point toward greater likelihood of long-term devil persistence than 219	
previously expected without any intervention. This conclusion comes from predictive modeling 220	
(Wells et al. 2017, 2019; Siska et al. 2018) as well as evidence of DFTD-relevant genetic 221	
variation (Margres et al. 2018a), recovery of DFTD-infected individuals (Pye et al. 2016a; 222	
Wright et al. 2017; Margres et al. 2018b), shifts in life history traits (Jones et al. 2008; Hamede 223	
et al. 2012; Lazenby et al. 2018; Russell et al. 2018), and rapid evolution at the genomic level in 224	
response to DFTD (Epstein et al. 2016; Hubert et al. 2018). This provides some margin of time 225	
to optimize conservation strategies with regard to adaptive genetic variation. Note, however, that 226	
the same models predict long-term persistence of devils at much lower population densities, 227	
particularly under scenarios in which DFTD also persists (Siska et al. 2018; Wells et al. 2019). 228	
Thus in the absence of any conservation actions, devils are likely to persist, but active 229	
management may be necessary if a conservation goal is to restore population densities and the 230	
ecological function of devils as the current apex mammalian predator and key scavenger 231	
(Hollings et al. 2015; Cunningham et al. 2018). Future research priorities include incorporating 232	
genetic variation and evolution in both devils and DFTD into predictive models, as well as 233	
empirically investigating coevolution between host and tumor. 234	
 Release of individuals from captivity into wild populations has the potential benefits of 235	
increasing numbers of individuals in these populations (i.e. demographic rescue), as well as 236	
increasing adaptive genetic diversity, potentially improving population fitness through genetic 237	
rescue. Attempts at genetic rescue carry the risk of outbreeding depression – reduced fitness as a 238	
result of erosion of locally adapted genotypes. Recent work shows that genetic rescue attempts 239	
often do not suffer from outbreeding depression and increase fitness (Frankham 2015; Whiteley 240	
et al. 2015). A notable exception to this trend is when captive populations are used as a source 241	
for translocation, because of the potentially rapid and unavoidable genetic changes that can occur 242	
in captivity (Whiteley et al. 2015). Additionally, genetic rescue is only appropriate if there is 243	
evidence of inbreeding depression or reduced fitness due to low genetic diversity (Weeks et al. 244	
2012; Whiteley et al. 2015). While devils have low genetic diversity and some populations have 245	
shown declines (Farquharson et al. 2018), there is no evidence for inbreeding depression in wild 246	
(Brüniche-Olsen et al. 2013) or captive (Gooley et al. 2017) populations, or genetic limits on 247	
devil population fitness. 248	
 Recent genomic and modeling results in devils discussed above suggest that the risks to 249	
release of captive individuals into natural populations may be substantial, and we argue against 250	
further release of captive individuals into DFTD-infected wild populations. Translocated 251	
individuals can carry deleterious alleles and counteract the effects of natural selection (for 252	
example in a salmonid fish; Ferchaud et al. 2018). In the case of devil populations this includes 253	
increasing the frequency of alleles conferring susceptibility to DFTD. Moreover, increasing the 254	
proportion or number of susceptible individuals would change the dynamics of the DFTD 255	
epidemic, increasing the force of infection and disease transmission rates, potentially 256	
outstripping any demographic or genetic gains (Wells et al. 2017). Because the insurance 257	
population was drawn from DFTD-free populations, with limited supplementation with orphans 258	
from diseased populations, and has not been managed for genetic factors explicitly related to 259	
DFTD, it is reasonable to assume that the captive population has higher frequencies of 260	
susceptible genotypes than natural populations that have evolved in response to DFTD (Epstein 261	
et al. 2016). As a result, perhaps counterintuitively, increasing natural population sizes in the 262	
short term with supplementation of captive individuals could have the long-term consequence of 263	
reducing population sizes because of changes in disease dynamics. 264	
We recommend genetic monitoring of allelic variation at DFTD-related loci in both 265	
captive and wild populations, as these loci continue to be identified. This would inform 266	
predictions about the future of the epidemic, as well as determining how the frequency of 267	
susceptible individuals would be affected by supplementation. Development of a panel of genetic 268	
markers that would predict individual-level susceptibility would also provide a tool for guiding 269	
captive breeding efforts toward natural devil populations that have the capacity to adapt to 270	
DFTD, and choosing individual devils for possible translocation from the captive population to 271	
the wild. To date, most loci identified as candidates from the selection and association tests 272	
described above (Table S1) have not been functionally validated, for instance by study of gene 273	
expression and function with transcriptomics, genetic manipulation in vitro, or other approaches. 274	
We do not advocate selecting for particular genotypes at a set of loci based on these published 275	
candidates. But as our understanding improves, management could include the goal of 276	
maintaining genetic variation at these loci where strong evidence for an association with DFTD-277	
related phenotypes is found, even if the complete mechanistic link remains unclear. Over the 278	
longer term, better understanding of the relationships among genetic variation, individual 279	
susceptibility, and population-level disease outcomes will inform other genetic management 280	
strategies. One important result of the predictive modeling and evidence for rapid evolution 281	
described above is that it may provide somewhat less urgency for active management, as 282	
unmanaged natural populations may be more likely to persist, although at lower densities, than 283	
previously predicted. We suggest that this time window should be used to evaluate potential 284	
genetic management strategies targeting DFTD-associated loci, as our understanding of these 285	
loci continues to improve. 286	
However, a risk of managing for DFTD-related genetic variation is adverse effects on 287	
variation important for other population stressors, such as habitat loss, anthropogenic mortality, 288	
or environmental change, or other pathogens. Remarkably, a second independent transmissible 289	
cancer was recently discovered in Tasmanian devils, called DFT2 (Pye et al. 2016b), suggesting 290	
that devils may be particularly susceptible to this unique type of disease. DFT2 appears to have 291	
broad similarities to DFTD (Stanmitz et al. 2018), suggesting that similar suites of genes 292	
involved in immune system function and cancer may be involved in potential resistance and 293	
evolutionary response to both diseases. The appearance of DFT2 raises the possibility of 294	
discovering and managing devil populations for genetic factors associated with resistance or 295	
other phenotypes associated with transmissible cancers in general, rather than DFTD 296	
specifically, but to date any host responses to DFT2 remain poorly understood. 297	
 Tasmanian devils face a unique conservation threat in the form of transmissible cancer, 298	
but the vast genetic resources available for the devil-DFTD system make the devil a potential 299	
model system for management of adaptive genetic variation. We urge continual re-evaluation of 300	
devil conservation strategies as our understanding advances. More broadly, the devil-DFTD 301	
system illustrates how modern advances in genomics can allow detection of adaptive or 302	
functionally significant loci in species of conservation concern, including loci associated with an 303	
acute threat to species persistence, such as disease. Identification of such loci should lead 304	
conservation biologists to consider the effects of current conservation strategies on this adaptive 305	
variation, and the potential utility of genetic management strategies for endangered populations 306	
beyond simple maximization of genetic diversity. 307	
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